ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0737

“It’ll Go Away. There’s Nothing Wrong with you:” the Experience of Pain-Related Stigma Among Adolescents with Pain Amplification Syndrome

Emily Wakefield1, William Zempsky1, Rebecca Puhl2 and Mark Litt3, 1Connecticut Children's/University of Connecticut School of Medicine, Hartford, CT, 2Rudd Center for Food Policy & Obesity/University of Connecticut, Hartford, CT, 3University of Connecticut School of Medicine, Farmington, CT

Meeting: ACR Convergence 2020

Keywords: fibromyalgia, pain, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Pediatric Rheumatology – Clinical Poster II: JIA

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic pain in adolescence is a complex and significant medical condition, with a reported prevalence of 11-38%.1 Pain amplification syndrome (PAS), which includes fibromyalgia, is a common chronic pain syndrome in adolescents characterized by allodynia without specific somatic injury or illness.2 Physicians are often puzzled by pain reports that seem disproportionate to medical findings. As a result, the complaints of adolescents with chronic pain are often viewed with skepticism by others. This disbelief is a phenomenon referred to as pain-related stigma.3 Pain-related stigma has not been studied in adolescents with chronic pain. Pain-related stigma may account for poor health outcomes in this population, such as depression,4 anxiety,5 problems in school6 and social impairment.7 In the current study, we sought to evaluate pain-related stigma in adolescents with PAS using focus group methodology.

Methods: Five focus groups of 3-5 adolescents with PAS (N=18), ages 12-17, were conducted to evaluate the impact of, and reaction to, pain-related stigma. Patients were recruited from an outpatient pediatric pain management clinic. Patients with a comorbid chronic medical condition, such as juvenile idiopathic arthritis, were excluded to reduce the bias of other disease-related stigma. Using a semi-structured interview, we asked questions targeting stigma in an open-ended manner. Focus group length ranged from 36-106 minutes with a total of 363 responses. Transcripts were validated for accuracy and coded independently by two raters (90.34% agreement) who identified pain-related themes using grounded theory.

Results: Findings suggest evidence of pain-related stigma among medical providers, school staff, peers and family members. Adolescents described sources of the pain-related stigma as the invisibility of pain and diagnostic uncertainty. Additionally, several incidents of peer bullying were also described secondary to respondent references to having chronic pain. There is evidence that adolescents with chronic pain attempt to conceal their symptoms from others to avoid negative social interactions, and that they internalize their pain-related stigma experiences.

Conclusion: Our findings indicate that adolescents with PAS experience pain-related stigma among medical providers, peers, school personnel and family members. Disbelief of pain symptoms may be critical in understanding disease-related burden and social disruptions in this population. There are several potential clinical implications of pain-related stigma among adolescents with chronic pain, including healthcare utilization, poor health outcomes and quality of healthcare.

Acknowledgments: This research is supported by the National Institute of Arthritis and Musculoskeletal and Skin Disease of the National Institutes of Health under award number 1K23AR073934-01A1 and the Goldfarb Pain and Palliative Medicine Fund.


Disclosure: E. Wakefield, None; W. Zempsky, None; R. Puhl, None; M. Litt, None.

To cite this abstract in AMA style:

Wakefield E, Zempsky W, Puhl R, Litt M. “It’ll Go Away. There’s Nothing Wrong with you:” the Experience of Pain-Related Stigma Among Adolescents with Pain Amplification Syndrome [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/itll-go-away-theres-nothing-wrong-with-you-the-experience-of-pain-related-stigma-among-adolescents-with-pain-amplification-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/itll-go-away-theres-nothing-wrong-with-you-the-experience-of-pain-related-stigma-among-adolescents-with-pain-amplification-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology